Wellmarker Bio
Wellmarker Bio, the company that specializes in first-in-class anticancer drug development was introduced as an innovative growth company in The Korea Economic Daily's TV program on November 28, 2020. With the hope to provide an appropriate drug to patients, Wellmarker Bio is developing anticancer drugs and predictive biomarkers based on the patient's unmet medical needs and is growing at a fast pace.
Last updated on
About Wellmarker Bio
Founded
2016Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$43MCategory
Industry
BiotechnologyLocation
City
SeoulState
SeoulCountry
South KoreaWellmarker Bio
Find your buyer within Wellmarker Bio